Your session is about to expire
← Back to Search
OMM for Parkinson's Disease
N/A
Waitlist Available
Led By Sheldon Yao, DO
Research Sponsored by New York Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Medically diagnosed with Parkinson's Disease
Over the age of 40
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
Study Summary
This trial is studying the effects of osteopathic manipulative medicine (OMM) on balance, motor function, and falls in people with Parkinson's disease (PD).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You have been diagnosed by a doctor with Parkinson's Disease.
Select...
You are older than 40 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10-weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of falls
Secondary outcome measures
Balance
Other outcome measures
Motor function
Serum biomarkers
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: OMM treatment armExperimental Treatment1 Intervention
Subject will receive osteopathic manipulative treatment protocol for Parkinson's disease (PARK-OMM), twice a week for 6 weeks.
Group II: CounselingActive Control1 Intervention
Subjects will receive counseling sessions weekly to match the face to face time with a physician during the OMM treatment arm. No OMM will be performed during this 6 week counseling study period.
Find a Location
Who is running the clinical trial?
American Osteopathic AssociationOTHER
19 Previous Clinical Trials
3,615 Total Patients Enrolled
New York Institute of TechnologyLead Sponsor
51 Previous Clinical Trials
2,021 Total Patients Enrolled
Sheldon Yao, DOPrincipal Investigator - NYIT College of Osteopathic Medicine
New York Institute of Technology
3 Previous Clinical Trials
110 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are older than 40 years old.You do not have a doctor's diagnosis of Parkinson's Disease.You have been diagnosed with other neurological diseases or disorders.You are unable to complete the assessment tools due to being in a wheelchair or having physical deformities.You have been diagnosed by a doctor with Parkinson's Disease.
Research Study Groups:
This trial has the following groups:- Group 1: OMM treatment arm
- Group 2: Counseling
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger